GOLDPLAT PLC

Share Issue/Capital Change • Oct 31, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7039R

Goldplat plc

31 October 2019

31 October 2019

Goldplat plc ('Goldplat' or 'the Company')

Grant of Options

Goldplat plc, the AIM listed gold producer with international gold recovery operations located in South Africa and Ghana and a gold mine in Kenya, is pleased to announce that on 30 October 2019 it granted an option to Werner Klingenberg, Chief Executive Officer, to subscribe for 3 million new ordinary shares of 1p each in the Company (the "Options").

The Options have an exercise price of 3.05 pence per share based on the closing mid-market price on 30 October 2019.  The Options will vest as to two thirds immediately and one third on 26 April 2020.  The exercise period of the Options is between 1 and 5 years from the vesting date.

The total number of share options outstanding following the grant of the Options is 8,666,667 representing 5.18% of the issued share capital of the Company.

For further information visit www.goldplat.com, follow on Twitter @GoldPlatPlc or contact:

Werner Klingenberg	Goldplat plc (CEO)	Tel: +27 (82) 051 1071
Colin Aaronson / Richard Tonthat / Ben Roberts	Grant Thornton UK LLP (Nominated Adviser)	Tel: +44 (0) 20 7383 5100
James Joyce / Lydia Zychowska	WH Ireland Limited (Broker)	Tel: +44 (0) 207 220 1666

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

IOEWGGQUUUPBGRU